Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.10.0.1
Segment Information (Tables)
9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Schedule of Segment Performance

The following tables summarize segment performance for the three and nine months ended September 30, 2018 and 2017 (in thousands):

 

 

 

Three months

ended September 30,

 

 

Nine months

ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Vascular

 

$

789

 

 

$

43

 

 

$

973

 

 

$

68

 

Dermatology

 

 

1,275

 

 

 

1,248

 

 

 

3,296

 

 

 

3,865

 

Net revenue

 

$

2,064

 

 

$

1,291

 

 

$

4,269

 

 

$

3,933

 

Vascular

 

$

579

 

 

$

52

 

 

$

1,050

 

 

$

60

 

Dermatology

 

 

701

 

 

 

641

 

 

 

1,956

 

 

 

2,447

 

Cost of revenue

 

$

1,280

 

 

$

693

 

 

$

3,006

 

 

$

2,507

 

Vascular

 

$

210

 

 

$

(9

)

 

$

(77

)

 

$

8

 

Dermatology

 

 

574

 

 

 

607

 

 

 

1,340

 

 

 

1,418

 

Gross profit

 

$

784

 

 

$

598

 

 

$

1,263

 

 

$

1,426

 

 

Schedule of Net Revenue Classified by Major Geographical Areas

Net revenue, classified by the major geographic areas in which our customers are located, was as follows:

 

 

Three months

ended September 30,

 

 

Nine months

ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

United States

 

$

1,992

 

 

$

1,178

 

 

$

3,900

 

 

$

3,648

 

All other countries

 

 

72

 

 

 

113

 

 

 

369

 

 

 

285

 

Net revenue

 

$

2,064

 

 

$

1,291

 

 

$

4,269

 

 

$

3,933